Publications by authors named "Sarah Abelev"

Claim this Profile
M
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22).
Llewellyn Mills, Jonathon C Arnold, Anastasia Suraev, Sarah V Abelev, Cilla Zhou

Harm Reduct J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey.
Thomas R Arkell, Sarah V Abelev, Llewellyn Mills, Anastasia Suraev, Jonathon C Arnold

J Cannabis Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study.
Sophie K Stack, Nial J Wheate, Niamh C Moloney, Sarah V Abelev, John W Barlow

J Pharm Technol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey.
Anastasia Suraev, Llewellyn Mills, Sarah V Abelev, Thomas R Arkell, Nicholas Lintzeris

Nat Sci Sleep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
Nicholas Lintzeris, Llewellyn Mills, Sarah V Abelev, Anastasia Suraev, Jonathon C Arnold

Harm Reduct J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation.
Sarah Abelev, Leon N Warne, Melissa Benson, Mark Hardy, Sunny Nayee

Med Cannabis Cannabinoids· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to cannabidiol without a prescription: A cross-country comparison and analysis.
Iain S McGregor, Elizabeth A Cairns, Sarah Abelev, Rhys Cohen, Mat Henderson

Int J Drug Policy· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients.
Melissa J Benson, Sarah V Abelev, Susan J Connor, Crispin J Corte, Lewis J Martin

Crohns Colitis 360· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease.
Melissa J Benson, Sarah V Abelev, Crispin J Corte, Susan J Connor, Iain S McGregor

Crohns Colitis 360· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
Lyndsey L Anderson, Nathan L Absalom, Sarah V Abelev, Ivan K Low, Peter T Doohan

Epilepsia· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic deletion of P-glycoprotein alters stress responsivity and increases depression-like behavior, social withdrawal and microglial activation in the hippocampus of female mice.
Natalia I Brzozowska, Kristie L Smith, Cilla Zhou, Peter M Waters, Ligia Menezes Cavalcante, Sarah V Abelev

Brain Behav Immun· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis